Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Immunology  |  Musculoskeletal  |  Rheumatology

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Cutaneous Lupus Erythematosus Clinical Trials

A listing of Cutaneous Lupus Erythematosus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (10) clinical trials

People with Cutaneous Lupus Erythematosus are asked to participate in a research study being conducted by Northwell Health, North Shore University Hospital.

Phase N/A

If you or a family member have cutaneous lupus erythematosus (CLE) and/or systemic lupus erythematosus (SLE), you may want to consider the LILAC clinical research study. What is the purpose of the LILAC study? The purpose of the LILAC study is to learn if an investigational medication may effectively reduce ...

Phase N/A

A research study is evaluating an investigational medication for cutaneous lupus erythematosus (CLE), or lupus-specific skin lesions, in women. This research study may be an option if you: Are a female 18-75 years of age Have been diagnosed with moderate to severe CLE Have had an inadequate response or intolerance ...

Phase N/A

Local doctors are looking for people with Cutaneous Lupus for clinical research studies of an investigational medication. Compensation provided for time and travel!

Phase N/A

Low-dose UVA1 Radiation in Cutaneous Lupus Patients

Study subjects will receive low dose (20 J/cm2) UVA1 phototherapy treatment three times per week for 10 weeks. Each treatment will take less than 30 minutes. This period will be followed by an eight-week observation phase to assess longer term effects of the treatment. Patients will be assessed for disease ...

Phase N/A

Duke Lupus Registry

The Duke Lupus Registry is a prospective cohort comprised of patients with lupus seen in the Duke Rheumatology clinic. The Duke Lupus Registry has two main purposes: 1. Improved patient care. By following disease activity scores and medication usage, we expect to improve our care of the patients seen in ...

Phase N/A

Duke Autoimmunity in Pregnancy Registry

Women with a systemic autoimmune disease that would be followed by a rheumatologist will be included in this study. All women will be seen every 4-6 weeks throughout pregnancy. At each visit, women will complete a questionnaire, the physician will determine the current level of disease activity, and a blood ...

Phase N/A

Cutaneous Lupus Erythematosus and Elidel

Lupus erythematosus is an autoimmune disease of unknown origin which is classified according to its clinical features, the course, and laboratory findings. A rough classification divides lupus erythematosus into three subgroups: 1. discoid lupus erythematosus (dLE), 2. subacute cutaneous lupus erythematosus (scLE), and 3. systemic lupus erythematosus (sLEsLE). The onset ...

Phase N/A

Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization

Systemic lupus erythematosus (SLE or lupus) is a chronic inflammatory autoimmune disorder of poorly understood etiology associated with a wide range of symptoms and physical findings. Many patients have incompletely controlled disease progressing to end-stage organ involvement. Recognizing and predicting flares and under associated organ damage would facilitate better treatment ...

Phase N/A

Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)

Discoid Lupus Erythematosus (DLE ) and systemic lupus erythematosus (SLE) can be devastating diseases with a significant impact on quality of life. DLE is currently treated with potent topical steroids, antimalarials, and immunosuppressants. Recent research has determined that DLE is a Th1 mediated disease. There is increasing evidence that JAK ...

Phase N/A